100 results
424B5
SLNO
Soleno Therapeutics Inc
2 May 24
Prospectus supplement for primary offering
4:04pm
the purchase contract, and the nature and amount of each of those securities, or the method of determining those amounts;
whether the purchase
S-3ASR
EX-4.3
SLNO
Soleno Therapeutics Inc
2 Jan 24
Automatic shelf registration
4:06pm
:
(a) a statement that the person making such certificate or opinion has read such covenant or condition;
(b) a brief statement as to the nature and scope
S-3ASR
myjxbjz60jqzb0qasc
2 Jan 24
Automatic shelf registration
4:06pm
D
t0pg5myzinw75z3r0
4 Oct 23
$59.99 mm in equity / options / securities to be acquired, sold $59.99 mm, 14 investors
10:36am
8-K
EX-1.1
7ldjcya
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-10.1
lj19uq
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-1.2
7uoena0g6vwno7ll
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
424B5
v3xefv35y wkkq
29 Sep 23
Prospectus supplement for primary offering
4:51pm
424B5
yzvtcygc etz4fu6fm
27 Sep 23
Prospectus supplement for primary offering
5:26pm
8-K
EX-10.3
uyts8y1fn4qirqmaxey2
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
8-K
EX-10.1
dyutmte2sc s3o1
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
8-K
EX-10.2
j3bki8i5eh1yx9on ri7
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm